Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma

Taiga Nishihori, May Abdo-Matkiwsky, Stewart B. Fleishman, Ronald H. Blum

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Interferon (IFN)-alpha 2b is used for adjuvant therapy in malignant melanoma. Neurotoxicity as a side effect has been well described. Resting and action tremor related to interferon have been reported but are relatively uncommon. We report a case of a delayed-onset interferon-related action tremor in a patient with malignant melanoma.

Original languageEnglish
Pages (from-to)526
Number of pages1
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume28
Issue number5
DOIs
StatePublished - Oct 2005
Externally publishedYes

Keywords

  • Action tremor
  • Interferon
  • Malignant melanoma

Fingerprint

Dive into the research topics of 'Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma'. Together they form a unique fingerprint.

Cite this